
Results
12
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
12 companies
Rubicon Research
Market Cap: ₹282.9b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,708.80
7D
-5.3%
1Y
n/a
Acutaas Chemicals
Market Cap: ₹271.3b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,313.40
7D
-2.3%
1Y
134.4%
Sakar Healthcare
Market Cap: ₹19.7b
Research, develops, manufactures, and sells pharmaceutical products in India.
SAKAR
₹884.85
7D
-1.0%
1Y
166.6%
Aether Industries
Market Cap: ₹216.8b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,633.90
7D
0.02%
1Y
122.0%
CORONA Remedies
Market Cap: ₹128.3b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,097.30
7D
-1.0%
1Y
n/a
Anthem Biosciences
Market Cap: ₹492.6b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹874.70
7D
-1.8%
1Y
4.6%
Emcure Pharmaceuticals
Market Cap: ₹350.3b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,846.90
7D
-1.5%
1Y
25.8%
Senores Pharmaceuticals
Market Cap: ₹68.2b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹1,480.40
7D
-3.7%
1Y
109.3%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹387.3b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹2,412.25
7D
0%
1Y
40.5%
Laurus Labs
Market Cap: ₹1.0t
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,866.20
7D
2.9%
1Y
114.8%
Shilpa Medicare
Market Cap: ₹168.6b
Offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.
530549
₹862.15
7D
6.4%
1Y
109.4%
Supriya Lifescience
Market Cap: ₹63.7b
Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
SUPRIYA
₹791.65
7D
-1.2%
1Y
20.3%